Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (west Africa) 1991

F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez

UI MeSH Term Description Entries
D006169 Guinea-Bissau A republic in western Africa, south of SENEGAL and west of GUINEA. Its capital is Bissau. Guinea, Portuguese,Portuguese Guinea,Guinea-Bissau, Republic of,Republic of Guinea-Bissau
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015491 HTLV-II Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2. Human T-lymphotropic Virus 2 Infection,Human T-lymphotropic Virus 2 Infections,Infections, HTLV-II,HTLV-II Infection,Human T lymphotropic Virus 2 Infection,Human T lymphotropic Virus 2 Infections,Infection, HTLV-II,Infections, HTLV II
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
August 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
March 1993, Journal of acquired immune deficiency syndromes,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
May 2003, Danish medical bulletin,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
October 2000, Journal of acquired immune deficiency syndromes (1999),
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
May 1994, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
September 2000, Acta tropica,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
November 1996, Journal of medical entomology,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
May 1998, International journal of cancer,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
January 2014, F1000Research,
F Lillo, and O E Varnier, and S Sabbatani, and A Ferro, and P Mendez
August 1993, BMJ (Clinical research ed.),
Copied contents to your clipboard!